Financing the correct rate of growth of medical technology.
This article suggests ways to preserve innovation while partially restraining the impressive growth rate in new medical technology. Health care will soon consume 12 percent of GNP. There is a wide range of opinions as to whether medical technology is a major or minor source of rising health care expenditures. Given our current fiscal problems, health care providers will be in direct competition with education and other domestic programs for a limited supply of R&D funds. More funding will have to come from the private sector. The challenge for prudent buyers of health care services is to control costs without eroding the biomedical capacity of the nation.
Eastaugh
S R
SR
George Washington University.
D004059:Diffusion of Innovation; D006291:Health Policy / Q000191:economics*; D011907:Rate Setting and Review; D012051:Reimbursement Mechanisms; D013673:Technology Assessment, Biomedical / Q000191:economics; D013675:Technology, High-Cost / Q000191:economics*; D014481:United States